Main competitors
Consensus (Composite) Analysts' target price evolution (4 months) Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Average Target P. Ecart obj. / dr Nbr of analysts
CHF 301.38 +16.95% 20
US$951.98 +22.42% 27
US$169.23 +8.62% 23
US$209.12 +10.2% 27
DKK 644.77 +43.3% 22
- CHF 120.28 -1.87% 19
GBX 183.89 +31.12% 20
US$101.79 +25.09% 24
US$314.27 +5.81% 28
US$29.14 +13.75% 23
US$116.81 +5.17% 26
US$500.23 +7.26% 28
€112.64 +35.18% 23
US$57.1 +21.38% 22
GBX 16.61 +17.47% 19
JP¥8,360.71 +21.13% 14
CN¥65.72 +23.07% 18
JP¥4,946.56 +12.6% 16
GBX 4.194 +12.99% 17
Average 905.6 +17.46% 22
Weighted average by Cap. 592.5 +18.23% 23
Other Pharmaceuticals